发明名称 Mtor Kinase Inhibitors For Oncology Indications And Diseases Associated With The MTOR/P13K/AKT Pathway
摘要 Provided herein are Heteroaryl Compounds having the following structure: wherein R 1 -R 3 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and a Heteroaryl Compound provided herein for use in a method of treating or preventing cancer, inflammatory conditions, immunological conditions, neurodegenerative diseases, diabetes, obesity, neurological disorders, age-related diseases, or cardiovascular conditions.
申请公布号 SG10201402267V(A) 申请公布日期 2014.07.30
申请号 SG10201402267V 申请日期 2009.10.27
申请人 SIGNAL PHARMACEUTICALS, LLC 发明人
分类号 主分类号
代理机构 代理人
主权项
地址